Biosyngen icon

Biosyngen

report entityclaim entity
BioSyngen is pioneering T-cell immunotherapies to combat various aggressive cancers. Committed to advancing innovative immune-cell therapy technologies, BioSyngen focuses on the clinical and commercial development of cutting-edge treatments aimed at transforming cancer care and improving patient outcomes.
National Ranking
1268th
in Singapore
Regional Ranking
2665th
in South East Asia
Global Ranking
77332nd
worldwide
Rankings by SemRush